Silence Therapeutics presented what seemed like positive data on zerlasiran, its experimental drug for reducing ...
Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback